Alissa K Greenberg

Summary

Affiliation: New York University
Country: USA

Publications

  1. pmc Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis
    Wei Min Gao
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    BMC Cancer 5:110. 2005
  2. pmc Performance of mitochondrial DNA mutations detecting early stage cancer
    John P Jakupciak
    Biochemical Science Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
    BMC Cancer 8:285. 2008
  3. ncbi request reprint Selective p38 activation in human non-small cell lung cancer
    Alissa K Greenberg
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, New York 10016, USA
    Am J Respir Cell Mol Biol 26:558-64. 2002
  4. pmc Preneoplastic lesions of the lung
    Alissa K Greenberg
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, New York University School of Medicine, New York, USA
    Respir Res 3:20. 2002
  5. ncbi request reprint Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators
    Alissa K Greenberg
    Department of Medicine, New York University School of Medicine, New York 10016, USA
    Am J Respir Cell Mol Biol 27:320-8. 2002
  6. ncbi request reprint Biomarkers for lung cancer: clinical uses
    Alissa K Greenberg
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, New York, USA
    Curr Opin Pulm Med 13:249-55. 2007
  7. pmc CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort
    Alissa K Greenberg
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, New York, USA
    PLoS ONE 7:e39403. 2012
  8. pmc Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
    William N Rom
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Radiology, Thoracic Surgery, and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    BMC Cancer 10:234. 2010
  9. pmc Aryl hydrocarbon receptor and lung cancer
    Junchieh J Tsay
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, NY, USA
    Anticancer Res 33:1247-56. 2013
  10. pmc S-adenosylmethionine as a biomarker for the early detection of lung cancer
    Alissa K Greenberg
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    Chest 132:1247-52. 2007

Detail Information

Publications13

  1. pmc Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis
    Wei Min Gao
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    BMC Cancer 5:110. 2005
    ..We hypothesized that distinctive profiles may result from the differential expression of relatively abundant serum proteins associated with the host response...
  2. pmc Performance of mitochondrial DNA mutations detecting early stage cancer
    John P Jakupciak
    Biochemical Science Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
    BMC Cancer 8:285. 2008
    ..The detection of mtDNA mutations in body fluids using resequencing microarrays, which are more sensitive than other sequencing methods, could provide a strategy to measure mutation loads in remote anatomical sites...
  3. ncbi request reprint Selective p38 activation in human non-small cell lung cancer
    Alissa K Greenberg
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, New York 10016, USA
    Am J Respir Cell Mol Biol 26:558-64. 2002
    ....
  4. pmc Preneoplastic lesions of the lung
    Alissa K Greenberg
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, New York University School of Medicine, New York, USA
    Respir Res 3:20. 2002
    ..In this review we summarize the data supporting the preneoplastic nature of these lesions, and delve into some of the genetic changes found in atypical adenomatous hyperplasia and squamous dysplasia/carcinoma in situ...
  5. ncbi request reprint Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators
    Alissa K Greenberg
    Department of Medicine, New York University School of Medicine, New York 10016, USA
    Am J Respir Cell Mol Biol 27:320-8. 2002
    ....
  6. ncbi request reprint Biomarkers for lung cancer: clinical uses
    Alissa K Greenberg
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, New York, USA
    Curr Opin Pulm Med 13:249-55. 2007
    ..All these areas of clinical management would benefit from sensitive and specific, noninvasive, cost-effective biomarkers...
  7. pmc CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort
    Alissa K Greenberg
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, New York, USA
    PLoS ONE 7:e39403. 2012
    ..We hypothesized that by reviewing demographic, clinical and nodule characteristics, we could identify risk factors associated with the presence of nodules on screening CT, and with the probability that a NCN was malignant...
  8. pmc Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
    William N Rom
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Radiology, Thoracic Surgery, and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    BMC Cancer 10:234. 2010
    ..Sera from lung cancer patients contain autoantibodies that react with tumor associated antigens (TAAs) that reflect genetic over-expression, mutation, or other anomalies of cell cycle, growth, signaling, and metabolism pathways...
  9. pmc Aryl hydrocarbon receptor and lung cancer
    Junchieh J Tsay
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, NY, USA
    Anticancer Res 33:1247-56. 2013
    ..In this review article we summarize the current understanding of AhR and its role in the development of lung cancer, including its influence on cell proliferation, angiogenesis, inflammation, and apoptosis...
  10. pmc S-adenosylmethionine as a biomarker for the early detection of lung cancer
    Alissa K Greenberg
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    Chest 132:1247-52. 2007
    ..We hypothesized that AdoMet levels were elevated in patients with lung cancer and may prove useful as a biomarker for early lung cancer...
  11. pmc Pulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry
    Jane P Ko
    Department of Radiology, New York University Langone Medical Center, 560 1st Ave, New York, NY 10016, USA
    Radiology 262:662-71. 2012
    ..To determine the precision of a three-dimensional (3D) method for measuring the growth rate of solid and subsolid nodules and its ability to detect abnormal growth rates...
  12. pmc Current readings: blood-based biomarkers for lung cancer
    Jun Chieh J Tsay
    Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, New York
    Semin Thorac Cardiovasc Surg 25:328-34. 2013
    ..In this article, we review recent literature on blood-based lung cancer biomarkers that we believe will have a significant role in enhancing screening efficacy in the near future. ..
  13. ncbi request reprint Basic pathogenetic mechanisms in silicosis: current understanding
    Binaya Rimal
    Division of Pulmonary and Critical Care Medicine, NYU School of Medicine, New York, New York 10016, USA
    Curr Opin Pulm Med 11:169-73. 2005
    ..Silicosis has been studied extensively by basic and clinical scientists, yet little is known about the crucial cellular and molecular mechanisms that initiate and propagate the process of inflammation and scarring...